ADTX Message Board Post 10000604 | ADiTx Therapeutics Inc.
home / stock / adtx / adtx message board
GS66
(investorshub)
Posted on: Oct/12/2022 14:01:47
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170176648
It is called anything to stop the bleeding.
News, Short Squeeze, Breakout and More Instantly...
-
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
-
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
-
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...